{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:07:39Z","timestamp":1778026059539,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017618","name":"Division of Diabetes, Endocrinology, and Metabolic Diseases","doi-asserted-by":"publisher","award":["NIH NIDDK T32 DK067872-17"],"award-info":[{"award-number":["NIH NIDDK T32 DK067872-17"]}],"id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10620-023-08023-y","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T09:01:31Z","timestamp":1689325291000},"page":"3781-3800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-7532","authenticated-orcid":false,"given":"David Uihwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Menegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuntal","family":"Bhowmick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reid","family":"Ponder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Hongyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KeeSeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie H.","family":"Urrunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"8023_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","volume":"18","author":"B Fosby","year":"2012","unstructured":"Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 2012;18:1\u201315.","journal-title":"World J Gastroenterol"},{"key":"8023_CR2","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol 2017;67:1298\u20131323.","journal-title":"J Hepatol"},{"key":"8023_CR3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary sclerosing cholangitis. N Engl J Med 2016;375:1161\u20131170.","journal-title":"N Engl J Med"},{"key":"8023_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jhep.2018.12.009","volume":"70","author":"F Durand","year":"2019","unstructured":"Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C. Age and liver transplantation. J Hepatol 2019;70:745\u2013758.","journal-title":"J Hepatol"},{"key":"8023_CR5","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1002\/hep.31647","volume":"73","author":"PM Barman","year":"2021","unstructured":"Barman PM, VanWagner LB. Cardiac risk assessment in liver transplant candidates: current controversies and future directions. Hepatology 2021;73:2564\u20132576.","journal-title":"Hepatology"},{"key":"8023_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","volume":"6","author":"S Feng","year":"2006","unstructured":"Feng S, Goodrich NP, Bragg-Gresham JL et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783\u2013790.","journal-title":"Am J Transplant"},{"key":"8023_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","volume":"20","author":"A Ricciuto","year":"2018","unstructured":"Ricciuto A, Kamath BM, Griffiths AM. The IBD and PSC Phenotypes of PSC-IBD. Curr Gastroenterol Rep 2018;20:16.","journal-title":"Curr Gastroenterol Rep"},{"key":"8023_CR8","doi-asserted-by":"publisher","first-page":"703310","DOI":"10.3389\/fcell.2021.703310","volume":"9","author":"R Linares","year":"2021","unstructured":"Linares R, Franc\u00e9s R, Guti\u00e9rrez A, Juanola O. Bacterial translocation as inflammatory driver in Crohn\u2019s disease. Front Cell Dev Biol 2021;9:703310.","journal-title":"Front Cell Dev Biol"},{"key":"8023_CR9","doi-asserted-by":"crossref","unstructured":"Mammadov RA, Selten JW, Roest HP, et al. Intestinal Bacteremia After Liver Transplantation is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis. Transplantation. Published online March 29, 2023.","DOI":"10.1097\/TP.0000000000004563"},{"key":"8023_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.dld.2018.02.014","volume":"50","author":"R Altwegg","year":"2018","unstructured":"Altwegg R, Combes R, Laharie D et al. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: a nationwide case series. Dig Liver Dis 2018;50:668\u2013674.","journal-title":"Dig Liver Dis"},{"key":"8023_CR11","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/ecco-jcc\/jjx057","volume":"11","author":"WMJ van Meeteren","year":"2017","unstructured":"van Meeteren WMJ, Hayee B, Inderson A et al. Safety of anti-TNF treatment in liver transplant recipients: a systematic review and meta-analysis. J Crohns Colitis 2017;11:1146\u20131151.","journal-title":"J Crohns Colitis"},{"key":"8023_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","volume":"11","author":"KK J\u00f8rgensen","year":"2013","unstructured":"J\u00f8rgensen KK, Lindstr\u00f6m L, Cvancarova M et al. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease. Clin Gastroenterol Hepatol 2013;11:517\u2013523.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8023_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cgh.2019.03.016","volume":"18","author":"PJ Thuluvath","year":"2020","unstructured":"Thuluvath PJ, Thuluvath AJ, Savva Y, Zhang T. Karnofsky performance status following liver transplantation in patients with multiple organ failures and probable acute-on-chronic liver failure. Clin Gastroenterol Hepatol 2020;18:234\u2013241.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8023_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"8023_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven DJ, B\u00fchlmann P. MissForest\u2013non-parametric missing value imputation for mixed-type data. Bioinformatics 2012;28:112\u2013118.","journal-title":"Bioinformatics"},{"key":"8023_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","volume":"33","author":"D Joshi","year":"2013","unstructured":"Joshi D, Bjarnason I, Belgaumkar A et al. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int 2013;33:53\u201361.","journal-title":"Liver Int"},{"key":"8023_CR17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1002\/lt.25838","volume":"26","author":"M Irl\u00e8s-Dep\u00e9","year":"2020","unstructured":"Irl\u00e8s-Dep\u00e9 M, Roullet S, Neau-Cransac M et al. Impact of preexisting inflammatory bowel disease on the outcome of liver transplantation for primary sclerosing cholangitis. Liver Transpl 2020;26:1477\u20131491.","journal-title":"Liver Transpl"},{"key":"8023_CR18","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weism\u00fcller","year":"2017","unstructured":"Weism\u00fcller TJ, Trivedi PJ, Bergquist A et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 2017;152:1975-1984.e8.","journal-title":"Gastroenterology"},{"key":"8023_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","volume":"63","author":"R Ravikumar","year":"2015","unstructured":"Ravikumar R, Tsochatzis E, Jose S et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol 2015;63:1139\u20131146.","journal-title":"J Hepatol"},{"key":"8023_CR20","first-page":"CD008794","volume":"2011","author":"JA Singh","year":"2011","unstructured":"Singh JA, Wells GA, Christensen R et al. Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 2011;2011:CD008794.","journal-title":"Cochrane Database Syst Rev"},{"key":"8023_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","volume":"155","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R. Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 2018;155:337-346.e10.","journal-title":"Gastroenterology."},{"key":"8023_CR22","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/j.cgh.2021.02.032","volume":"20","author":"S Singh","year":"2022","unstructured":"Singh S, Heien HC, Herrin J et al. Comparative risk of serious infections with tumor necrosis factor \u03b1 antagonists vs vedolizumab in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2022;20:e74\u2013e88.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08023-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:09:14Z","timestamp":1692756554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08023-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["8023"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08023-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript certify they share no affiliation or involvement with any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}